CIK 0001750149 · Non-accelerated filer<br>Smaller reporting company
Inhibikase Therapeutics, Inc.
Sign in to watch- Ticker
- IKT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 263407249
- Phone
- (302) 295-3800
- Business address
- 1000 N. WEST STREET, SUITE 1200, WILMINGTON, DE, 19801
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-30 | BERMAN DENNIS N Director | Grant or award · Stock Option (right to buy) | +6,667 | 6,667 | ||
| 2023-06-30 | Dion Gisele Director | Grant or award · Stock Option (right to buy) | +6,667 | 6,667 | ||
| 2023-06-30 | GRINT PAUL C Director | Grant or award · Stock Option (right to buy) | +6,667 | 6,667 | ||
| 2023-06-30 | Freeman Roy Lester Director | Grant or award · Stock Option (right to buy) | +6,667 | 6,667 | ||
| 2023-03-01 | Werner Milton H. President and CEO | Grant or award · Stock Option (right to buy) | +210,000 | 210,000 | ||
| 2023-03-01 | FRATTAROLI JOSEPH Cheif Financial Officer | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2022-09-01 | Dion Gisele Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2022-08-16 | Werner Milton H. President and CEO | Purchase | +5,000 | $0.80 | $4K | 5,335,433 |
| 2022-06-24 | Freeman Roy Lester Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-06-24 | GRINT PAUL C Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-06-24 | O'Farrell Elizabeth G. Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-06-24 | BERMAN DENNIS N Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-05-27 | Werner Milton H. President and CEO | Purchase | +5,000 | $0.98 | $5K | 5,330,433 |
| 2022-05-20 | Werner Milton H. President and CEO | Purchase | +10,000 | $0.60 | $6K | 5,325,433 |
| 2022-05-19 | FRATTAROLI JOSEPH Chief Financial Officer | Purchase | +3,948 | $0.64 | $3K | 48,091 |
| 2022-03-07 | FRATTAROLI JOSEPH Chief Financial Officer | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2022-03-07 | Werner Milton H. President and CEO | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2022-03-07 | FRATTAROLI JOSEPH Cheif Financial Officer | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2022-03-07 | Werner Milton H. President and CEO | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2022-01-03 | Werner Milton H. President and CEO | Option exercise | +21,853 | $2.02 | $44K | 5,315,433 |
Page 7 of 9 · 163 trades